cantuzumab
pertuzumab
labetuzumab
scintimammography
antinucleotide
milatuzumab
patritumab
farletuzumab
teprotumumab
mosunetuzumab
mammothermography
adenoma
igovomab
neoplastic cell
cedelizumab
tasonermin
votumumab
oncoimmunotherapy
arcitumomab
antithyroglobulin
immunocytokine
immunotherapy
pancytokeratin
siltuximab
-tum-
robatumumab
cancer cell
tisotumab vedotin
cytotoxic reaction
soravtansine
cergutuzumab
apolizumab
boob cancer
immunoblastoma
iratumumab
amivantamab
citatuzumab bogatox
amazia
etaracizumab
oregovomab
antisynthetase
immunocytoma
intrabody
immunobinding
malignin
agonistic monoclonal antibody
olendalizumab
oophoroma
perimammary